Literature DB >> 9508787

Molecular characterization of a dual endothelin-1/Angiotensin II receptor.

N Ruiz-Opazo1, K Hirayama, K Akimoto, V L Herrera.   

Abstract

BACKGROUND: The molecular recognition theory (MRT) provides a conceptual framework that could explain the evolution of intermolecular and intramolecular interaction of peptides and proteins. As such, it predicts that binding sites of peptide hormones, and its receptor binding sites were originally encoded by and evolved from complementary strands of genomic DNA.
MATERIALS AND METHODS: On the basis of principles underlying the MRT, we screened a rat brain complementary DNA library using an AngII followed by an endothelin-1 (ET-1) antisense oligonucleotide probe, expecting to isolate potential cognate receptors.
RESULTS: An identical cDNA clone was isolated independently from both the AngII and ET-1 oligonucleotide screenings. Structural analysis revealed a receptor polypeptide containing a single predicted transmembrane region with distinct ET-1 and AngII putative binding domains. Functional analysis demonstrated ET-1- and AngII-specific binding as well as ET-1- and AngII-induced coupling to a Ca2+ mobilizing transduction system. Amino acid substitutions within the predicted ET-1 binding domain obliterate ET-1 binding while preserving AngII binding, thus defining the structural determinants of ET-1 binding within the dual ET-1/AngII receptor, as well as corroborating the dual nature of the receptor.
CONCLUSIONS: Elucidation of the dual ET-1/AngII receptor provides further molecular genetic evidence in support of the molecular recognition theory and identifies for the first time a molecular link between the ET-1 and AngII hormonal systems that could underlie observed similar physiological responses elicited by ET-1 and AngII in different organ systems. The prominent expression of the ET-1/AngII receptor mRNA in brain and heart tissues suggests an important role in cardiovascular function in normal and pathophysiological states.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9508787      PMCID: PMC2230307     

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  40 in total

1.  Identification of a domain of ETA receptor required for ligand binding.

Authors:  M Adachi; Y Y Yang; A Trzeciak; Y Furuichi; C Miyamoto
Journal:  FEBS Lett       Date:  1992-10-19       Impact factor: 4.124

2.  Identification of specific intracellular domains of the human ETA receptor required for ligand binding and signal transduction.

Authors:  K Hashido; M Adachi; T Gamou; T Watanabe; Y Furuichi; C Miyamoto
Journal:  Cell Mol Biol Res       Date:  1993

Review 3.  Endothelins: circulating plasma levels and presence in other biologic fluids.

Authors:  B Battistini; P D'Orléans-Juste; P Sirois
Journal:  Lab Invest       Date:  1993-06       Impact factor: 5.662

4.  Structure-activity relationships of endothelin: importance of the C-terminal moiety.

Authors:  S Kimura; Y Kasuya; T Sawamura; O Shinmi; Y Sugita; M Yanagisawa; K Goto; T Masaki
Journal:  Biochem Biophys Res Commun       Date:  1988-11-15       Impact factor: 3.575

5.  Is there a relationship between DNA sequences encoding peptide ligands and their receptors?

Authors:  A Goldstein; D L Brutlag
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

6.  The Na-K-Cl cotransport protein of shark rectal gland. II. Regulation by direct phosphorylation.

Authors:  C Lytle; B Forbush
Journal:  J Biol Chem       Date:  1992-12-15       Impact factor: 5.157

7.  Cloning and characterization of an endothelin-3 specific receptor (ETC receptor) from Xenopus laevis dermal melanophores.

Authors:  S Karne; C K Jayawickreme; M R Lerner
Journal:  J Biol Chem       Date:  1993-09-05       Impact factor: 5.157

8.  Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition.

Authors:  Y Kambayashi; S Bardhan; K Takahashi; S Tsuzuki; H Inui; T Hamakubo; T Inagami
Journal:  J Biol Chem       Date:  1993-11-25       Impact factor: 5.157

9.  Lack of interaction of vasopressin with its antisense peptides: a functional and immunological study.

Authors:  M Jurzak; I Pavo; F Fahrenholz
Journal:  J Recept Res       Date:  1993

10.  Isoform-specific modulation of Na+, K+-ATPase alpha-subunit gene expression in hypertension.

Authors:  V L Herrera; A V Chobanian; N Ruiz-Opazo
Journal:  Science       Date:  1988-07-08       Impact factor: 47.728

View more
  12 in total

1.  Molecular imaging of vasa vasorum neovascularization via DEspR-targeted contrast-enhanced ultrasound micro-imaging in transgenic atherosclerosis rat model.

Authors:  Julius L Decano; Anne Marie Moran; Nelson Ruiz-Opazo; Victoria L M Herrera
Journal:  Mol Imaging Biol       Date:  2011-12       Impact factor: 3.488

Review 2.  Endothelin receptors: what's new and what do we need to know?

Authors:  Stephanie W Watts
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-11-11       Impact factor: 3.619

3.  Endothelin mediates some of the renal actions of acutely administered angiotensin II.

Authors:  A Riggleman; J Harvey; C Baylis
Journal:  Hypertension       Date:  2001-07       Impact factor: 10.190

4.  DEspR T/CATAAAA-box promoter variant decreases DEspR transcription and is associated with increased BP in Sardinian males.

Authors:  Nicola Glorioso; Victoria L M Herrera; Tamara Didishvili; Giuseppe Argiolas; Chiara Troffa; Patrizia Bulla; Emanuela Bulla; Nelson Ruiz-Opazo
Journal:  Physiol Genomics       Date:  2011-08-23       Impact factor: 3.107

Review 5.  Endothelin in cardiovascular control: the role of endothelin antagonists.

Authors:  R R Wenzel; P Czyborra; T Lüscher; T Philipp
Journal:  Curr Hypertens Rep       Date:  1999 Feb-Mar       Impact factor: 5.369

6.  Endothelin-A receptor antagonist inhibits angiotensin II and noradrenaline in man.

Authors:  R R Wenzel; J Rüthemann; H Bruck; R F Schäfers; M C Michel; T Philipp
Journal:  Br J Clin Pharmacol       Date:  2001-08       Impact factor: 4.335

Review 7.  The cardiovascular physiology and pharmacology of endothelin-1.

Authors:  Eric Thorin; Martine Clozel
Journal:  Adv Pharmacol       Date:  2010

8.  Sex-specific hippocampus-dependent cognitive deficits and increased neuronal autophagy in DEspR haploinsufficiency in mice.

Authors:  Victoria L M Herrera; Julius L Decano; Pia Bagamasbad; Timothy Kufahl; Martin Steffen; Nelson Ruiz-Opazo
Journal:  Physiol Genomics       Date:  2008-09-09       Impact factor: 3.107

9.  Confirmation of translatability and functionality certifies the dual endothelin1/VEGFsp receptor (DEspR) protein.

Authors:  Victoria L M Herrera; Martin Steffen; Ann Marie Moran; Glaiza A Tan; Khristine A Pasion; Keith Rivera; Darryl J Pappin; Nelson Ruiz-Opazo
Journal:  BMC Mol Biol       Date:  2016-06-14       Impact factor: 2.946

10.  DEspRhigh neutrophils are associated with critical illness in COVID-19.

Authors:  Joanne T deKay; Ivette F Emery; Jonathan Rud; Ashley Eldridge; Christine Lord; David J Gagnon; Teresa L May; Victoria L M Herrera; Nelson Ruiz-Opazo; Richard R Riker; Douglas B Sawyer; Sergey Ryzhov; David B Seder
Journal:  Sci Rep       Date:  2021-11-17       Impact factor: 4.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.